pamidronate has been researched along with Osseous Paget's Disease in 175 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We studied patterns of pagetic pain in relation to physical activity, and the effect of coexistent osteoarthritis (OA)/pagetic arthropathy on pain and physical activity before and after treatment with pamidronate." | 7.72 | Patterns of pain in Paget's disease of bone and their outcomes on treatment with pamidronate. ( Mehan, R; Miller, H; Swinson, DR; Talwalkar, A; Vasireddy, S, 2003) |
| "Spinal stenosis is a serious complication of Paget's disease of bone." | 5.29 | Pamidronate treatment of the neurologic sequelae of pagetic spinal stenosis. ( Reid, IR; Wallace, E; Wong, J, 1995) |
| "It was established that in the course of pamidronate infusion therapy BE levels remained constant, whereas the values in serum alkaline phosphatase and pain intensity scores were significantly reduced." | 5.12 | The analgesic effect of pamidronate is not caused by the elevation of beta endorphin level in Paget's disease--a controlled pilot study. ( Barna, I; Bender, T; Donáth, J; Gergely, P; Poór, G, 2006) |
| "Pamidronate has a pharmacologic profile similar to that of etidronate, but pamidronate is more potent and has a longer duration of effect." | 3.77 | Pamidronate. ( Kellihan, MJ; Mangino, PD, 1992) |
| " We studied patterns of pagetic pain in relation to physical activity, and the effect of coexistent osteoarthritis (OA)/pagetic arthropathy on pain and physical activity before and after treatment with pamidronate." | 3.72 | Patterns of pain in Paget's disease of bone and their outcomes on treatment with pamidronate. ( Mehan, R; Miller, H; Swinson, DR; Talwalkar, A; Vasireddy, S, 2003) |
| "Inhibition of skeletal mineralisation is a well-recognized complication of disodium etidronate therapy that was identified in the earliest studies of its use in osteoporosis and Paget's disease." | 3.70 | Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease. ( MacGowan, JR; Morris, VH; Pringle, J; Stamp, TC, 2000) |
| " The hemifacial spasm failed to resolve with intravenous pamidronate." | 3.69 | Hemifacial spasm and osteitis deformans. ( Bosley, TM; Ing, EB; Kelepouris, N; Savino, PJ; Sergott, RC, 1995) |
| "Pamidronate is a bisphosphonate whose short-term biological efficacy in Paget's disease of bone was convincingly established many years ago." | 2.69 | Effect of multiple intravenous pamidronate courses in Paget's disease of bone. ( Arlot, M; Meunier, PJ; Thevenon, J; Trombetti, A; Uebelhart, B, 1999) |
| " Study 1 is a retrospective study of 20 patients with moderate to severe disease who were treated with intravenous (iv) pamidronate (221 +/- 18 mg [SEM]; range 60-360 mg), and after biochemical remission and relapse were retreated with generally larger iv dosage (293 +/- 28 mg; range 180-600 mg)." | 2.69 | Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another. ( Bhagat, CI; Criddle, A; Faulkner, DL; Gan, SK; Geelhoed, E; Gutteridge, DH; Kent, GN; Price, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG; Vasikaran, S; Ward, LC; Will, RK, 1999) |
| "An intravenous dosage schedule using pamidronate disodium, based on biochemical severity, was used to treat 71 patients with Paget's disease who had no previous bisphosphonate treatment." | 2.68 | Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study. ( Bhagat, CI; Gutteridge, DH; Kent, GN; Nicholson, GC; Price, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG; Thompson, RI; Ward, LC, 1996) |
| "Urinary parameters of bone resorption, free pyridinolines (Pyr) and hydroxyproline (OHP), as well as serum tartrate-resistant acid phosphatase (TRAP) were measured." | 2.68 | Pamidronate and biochemical markers of bone turnover. ( Del Campo, MT; Gijón, J; Martínez, ME; Plaza, MA; Torrijos, A, 1997) |
| " Efficacy on laboratory parameters was greater in the higher dosage group." | 2.68 | Pamidronate infusions for the treatment of Paget's disease of bone. ( Ahmed, I; Bon, E; Cantagrel, A; Laroche, M; Mazieres, B; Moulinier, L, 1996) |
| "Pamidronate treatment for Paget's disease of bone leads to a sustained inhibition of elevated bone turnover." | 2.68 | [Bisphosphonate therapy of Paget's disease of bone with pamidronate]. ( Grauer, A; Klar, B; Knaus, J; Scharla, SH; Ziegler, R, 1996) |
| " Four of the six patients in group 1A achieved normal ALP, whereas ALP remained at an increased level in all of the 10 patients in group 2 whose pretreatment ALP was greater than 1000 U/l, suggesting that a dose-response effect exists." | 2.67 | Clinical experience with pamidronate in the treatment of Paget's disease of bone. ( Boyce, BF; Boyle, IT; Gallacher, SJ; Jenkins, A; Patel, U; Ralston, SH, 1991) |
| "Pamidronate is a second generation bisphosphonate that has been used in Europe for the treatment of Paget's disease of bone for several years." | 2.67 | Effects of intravenous pamidronate therapy on Paget's disease of bone. ( Bombassei, GJ; Raisz, LG; Yocono, M, 1994) |
| " We have evaluated the effectiveness of three dosage regimes of aminohydroxypropylidene bisphosphonate (pamidronate) in 15 patients with extensive Paget's disease who had become refractory to conventional therapy." | 2.67 | Pamidronate is effective for Paget's disease of bone refractory to conventional therapy. ( Gunasekera, RD; Wimalawansa, SJ, 1993) |
| "Paget's disease of bone is a focal skeletal disorder characterized by the formation of structurally abnormal bone, deformity and other complications leading to significant disability and bone pain." | 2.45 | The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone. ( De Paola, V; Gennari, L; Martini, G; Merlotti, D; Mossetti, G; Nuti, R; Rendina, D, 2009) |
| "Paget disease of bone is a disorder of unknown etiology involving disturbances in bone remodeling, typically leading to bone pain and other complications such as skeletal deformities, fractures, hearing loss, and neurologic complications." | 2.44 | Paget disease of bone: therapeutic options. ( Silverman, SL, 2008) |
| " Bisphosphonates restore normal bone turnover and relieve bone pain, but oral formulations may be limited by complicated dosing regimens and poor gastrointestinal absorption." | 2.44 | A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg. ( Abelson, A, 2008) |
| "Inhibitors of bone resorption have been used to suppress bone turnover in the short term, but there is no published data on long-term efficacy." | 2.42 | Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy. ( Cundy, T; King, A; Wheadon, L, 2004) |
| "Pamidronate (APD) is a potent inhibitor of bone resorption that is useful in the management of patients with osteolytic bone metastases from breast cancer or multiple myeloma, tumour-induced hypercalcaemia or Paget's disease of bone." | 2.40 | Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone. ( Coukell, AJ; Markham, A, 1998) |
| " Long term use of low-dose pamidronate in conjunction with conventional antiosteoporotic therapy may halt bone loss in steroid-induced and idiopathic osteoporosis." | 2.38 | Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. ( Fitton, A; McTavish, D, 1991) |
| "Fast bone resorption and formation lead to the development of disorganized bone tissue." | 1.72 | Updates on Paget's Disease of Bone. ( Choi, YJ; Chung, YS; Sohn, YB, 2022) |
| "Pamidronate treatment with vitamin D sufficiency can be effective therapy for the skeletal disease caused by the OPG deficiency form of JPD." | 1.39 | Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation. ( Karamizadeh, Z; McAlister, WH; Mumm, S; Nasirabadi, S; Saki, F; Whyte, MP, 2013) |
| "Hypercalcemia is rare and when it is diagnosed, primary hyperparathyroidism should be ruled out." | 1.35 | [Paget's disease and hypercalcemia: coincidence or causal relationship?]. ( Altman, A; Green, I, 2009) |
| "Oral pamidronate was added after 11 months of i." | 1.32 | Chronic idiopathic hyperphosphatasia: normalization of bone turnover with cyclical intravenous pamidronate therapy. ( Alvarez, V; Casco, C; Mautalen, C; Rubinstein, M; Tau, C, 2004) |
| "Pamidronate treatment (60 mg/day for 3 days) was repeated in patients without evidence of PDB remission at day 120." | 1.32 | Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates. ( Mossetti, G; Nunziata, V; Rendina, D; Sorrentino, M; Viceconti, R, 2004) |
| "Conversely, in Paget's disease and prostate cancer-induced bone metastases, conditions characterized by focal increased bone turnover, alpha L CTX levels were more elevated than those of age-related CTX forms, resulting in increased ratios between native and age-modified CTX." | 1.32 | Investigation of bone disease using isomerized and racemized fragments of type I collagen. ( Body, JJ; Christgau, S; Christiansen, C; Cloos, PA; Delmas, P; Engsig, M; Fledelius, C; Garnero, P, 2003) |
| "pamidronate was given for 6 months." | 1.31 | [Fibrous dysplasia: differential diagnosis from Paget's disease]. ( Heilmann, P; Kasperk, Ch; Nawroth, P; Schulz, A; Wagner, P, 2002) |
| "The various features of carcinoid tumors metastasizing to the skeleton are briefly reviewed." | 1.31 | Case of an ivory vertebra. ( Ball, DW; Basaria, S; Belzberg, AJ; McCarthy, EF, 2000) |
| "Pamidronate treatment did not influence the concentration of beta2-microglobulin and assessment of beta2-microglobulin in Paget's disease bone is no asset." | 1.30 | [Is beta 2-microglobulin a marker of bone remodeling in Paget's disease of bone?]. ( Wilczek, H, 1997) |
| "In all 24 patients studied, bone resorption (measured by urinary hydroxyproline/creatinine ratio, OHP/Cr) fell sharply on treatment, from 0." | 1.29 | Long-term elevation of 1,25-dihydroxyvitamin D after short-term intravenous administration of pamidronate (aminohydroxypropylidene bisphosphonate, APD) in Paget's disease of bone. ( Devlin, RD; Fenton, AJ; Grill, V; Gutteridge, DH; Kent, GN; Prince, RL; Retallack, RW; Worth, GK, 1994) |
| "Pamidronate treatment in patients with Paget's disease of bone is effective and safe." | 1.29 | [Paget's disease of bone and treatment with pamidronate]. ( Stĕpán, J; Wilczek, H, 1993) |
| "Paget's disease of bone is a localized progressive disease, characterized by increased bone remodeling, bone hypertrophy, and abnormal bone structure, leading to pain and deformity." | 1.29 | Therapeutic strategy in Paget's disease of bone. ( Meunier, PJ; Vignot, E, 1995) |
| " Although there was no significant difference in response between the lower dosage groups, there was a greater response in patients treated with a higher dose of APD." | 1.29 | Single-day intravenous pamidronate in Paget's disease. ( Clifton-Bligh, P; Forman, L; Hooper, MJ; Lang, FV; Marel, GM; McDowall, D; Tancred, J, 1994) |
| "The rate and degree of suppression of bone resorption were monitored in 6 of the patients similarly treated with intravenous dimethyl-APD at a dose of 4 mg/day for 10 days, by daily measurements of the 24 h urinary excretion of Pyr, Dpyr and OHP." | 1.29 | Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone? ( Colwell, A; Eastell, R; Hamdy, NA; Papapoulos, SE; Russell, RG, 1993) |
| "Spinal stenosis is a serious complication of Paget's disease of bone." | 1.29 | Pamidronate treatment of the neurologic sequelae of pagetic spinal stenosis. ( Reid, IR; Wallace, E; Wong, J, 1995) |
| " This potentially serious drug side-effect does not appear to have been reported previously in patients with Paget's disease." | 1.29 | Ototoxicity associated with intravenous bisphosphonate administration. ( Mills, DA; Reid, IR; Wattie, DJ, 1995) |
| "Treatment with pamidronate normalized serum calcium concentration and induced a complete biochemical remission." | 1.28 | Paget's disease with osteolytic lesions: combining medical and surgical treatments. ( Bloem, RM; Brumsen, C; Papapoulos, SE, 1992) |
| "Pamidronate was well tolerated; femoral neck fractures occurred in 2 subjects with severe local Paget's disease but were unlikely to be due to the drug." | 1.28 | Single-dose intravenous pamidronate is effective alternative therapy for Paget's disease refractory to calcitonin. ( Galligan, JP; Jacobi, JM; Khafagi, FA; Mortimer, RH; Perry-Keene, DA; Yap, AS, 1991) |
| "Several agents are available for treatment of Paget's disease of bone, but their long-term use may be limited by resistance or adverse effects." | 1.28 | Successful treatment of resistant Paget's disease of bone with pamidronate. ( Mallette, LE, 1989) |
| "Its oral use in Paget's disease of bone has proved effective and safe when the drug is administered on a long-term basis." | 1.27 | [Paget's disease of bone treated per os with APD in 5 days]. ( Burckhardt, P; Jaeger, P; Thiébaud, D, 1986) |
| "Eight patients suffered a recurrence after discontinuation of APD." | 1.27 | Quantitative bone scintigraphy in Paget's disease treated with APD. ( Bijvoet, OL; Frijlink, WB; Harinck, HI; Pauwels, EK; Vellenga, CJ, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (22.29) | 18.7374 |
| 1990's | 93 (53.14) | 18.2507 |
| 2000's | 37 (21.14) | 29.6817 |
| 2010's | 3 (1.71) | 24.3611 |
| 2020's | 3 (1.71) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, YJ | 1 |
| Sohn, YB | 1 |
| Chung, YS | 1 |
| Maatallah, K | 1 |
| Ben Nessib, D | 1 |
| Labbène, E | 1 |
| Ferjani, H | 1 |
| Bouaziz, M | 1 |
| Kaffel, D | 1 |
| Hamdi, W | 1 |
| Höppner, J | 1 |
| Steff, K | 1 |
| Lobert, F | 1 |
| Heyer, CM | 1 |
| Hauffa, BP | 1 |
| Grasemann, C | 1 |
| Gonc, EN | 1 |
| Ozon, A | 1 |
| Buyukyilmaz, G | 1 |
| Alikasifoglu, A | 1 |
| Simsek, OP | 1 |
| Kandemir, N | 1 |
| Whyte, MP | 2 |
| Tau, C | 2 |
| McAlister, WH | 2 |
| Zhang, X | 1 |
| Novack, DV | 1 |
| Preliasco, V | 1 |
| Santini-Araujo, E | 1 |
| Mumm, S | 2 |
| Silverman, SL | 1 |
| Seehra, J | 1 |
| Sloan, P | 1 |
| Oliver, RJ | 1 |
| Gennari, L | 3 |
| Merlotti, D | 3 |
| Mossetti, G | 2 |
| Rendina, D | 2 |
| De Paola, V | 3 |
| Martini, G | 3 |
| Nuti, R | 3 |
| Green, I | 1 |
| Altman, A | 1 |
| Saki, F | 1 |
| Karamizadeh, Z | 1 |
| Nasirabadi, S | 1 |
| Isasi, C | 1 |
| Sanz, J | 1 |
| Hijós, M | 1 |
| Vaquero, M | 1 |
| Saucedo, G | 1 |
| Andreu, JL | 1 |
| Cloos, PA | 1 |
| Fledelius, C | 2 |
| Christgau, S | 1 |
| Christiansen, C | 3 |
| Engsig, M | 1 |
| Delmas, P | 1 |
| Body, JJ | 1 |
| Garnero, P | 3 |
| Wagner, P | 1 |
| Heilmann, P | 1 |
| Schulz, A | 1 |
| Nawroth, P | 1 |
| Kasperk, Ch | 1 |
| Sprecher, S | 1 |
| Steinberg, R | 1 |
| Lichtenstein, D | 1 |
| Witt, KM | 1 |
| Barginear, M | 1 |
| Montagnani, A | 1 |
| Gonnelli, S | 1 |
| Cepollaro, C | 1 |
| Campagna, MS | 1 |
| Franci, MB | 2 |
| Pacini, S | 1 |
| Gennari, C | 1 |
| Gutteridge, DH | 12 |
| Retallack, RW | 10 |
| Ward, LC | 7 |
| Price, RI | 7 |
| Stewart, GO | 8 |
| Stuckey, BG | 9 |
| Prince, RL | 10 |
| Kent, GN | 11 |
| Bhagat, CI | 9 |
| Thompson, RI | 3 |
| Nicholson, GC | 4 |
| Naylor, KE | 1 |
| Jackson, B | 1 |
| Eastell, R | 2 |
| Joshua, F | 1 |
| Epstein, M | 1 |
| Major, G | 1 |
| Donáth, J | 2 |
| Krasznai, M | 1 |
| Fornet, B | 1 |
| Gergely, P | 2 |
| Poór, G | 2 |
| Vasireddy, S | 1 |
| Talwalkar, A | 1 |
| Miller, H | 1 |
| Mehan, R | 1 |
| Swinson, DR | 1 |
| Walsh, JP | 1 |
| Will, RK | 3 |
| Criddle, RA | 1 |
| Dhaliwal, SS | 2 |
| Drury, PJ | 1 |
| Vasikaran, S | 2 |
| Cundy, T | 3 |
| Wheadon, L | 1 |
| King, A | 2 |
| Viceconti, R | 1 |
| Sorrentino, M | 1 |
| Nunziata, V | 1 |
| Mautalen, C | 5 |
| Casco, C | 2 |
| Alvarez, V | 1 |
| Rubinstein, M | 1 |
| Crisp, AJ | 5 |
| Tran, HA | 1 |
| Brixen, KT | 1 |
| Abrahamsen, B | 1 |
| Kassem, MS | 1 |
| Mosekilde, L | 1 |
| Carter, G | 1 |
| Goss, AN | 1 |
| Doecke, C | 1 |
| Murdin, L | 1 |
| Yeoh, LH | 1 |
| Orcel, P | 1 |
| Rousière, M | 1 |
| Bender, T | 1 |
| Barna, I | 1 |
| Salvadori, S | 1 |
| Campagna, S | 1 |
| Avanzati, A | 2 |
| Valleggi, F | 2 |
| Bhatt, K | 1 |
| Balakrishnan, C | 1 |
| Mangat, G | 1 |
| Bajan, K | 1 |
| Ashavaid, T | 1 |
| Joshi, VR | 1 |
| Griz, L | 1 |
| Colares, V | 1 |
| Bandeira, F | 1 |
| Papapoulos, SE | 9 |
| Eekhoff, EM | 1 |
| Zwinderman, AH | 2 |
| Abelson, A | 1 |
| Gueiros, LA | 1 |
| Lopes, MA | 1 |
| Leão, JC | 1 |
| Bijvoet, OL | 13 |
| Reitsma, PH | 2 |
| Frijlink, WB | 5 |
| Mautalen, CA | 4 |
| Fraser, TR | 2 |
| Ibbertson, HK | 3 |
| Holdaway, IM | 2 |
| Rutland, M | 1 |
| Dodd, G | 1 |
| Wattie, DJ | 2 |
| Jie, K | 1 |
| van der Linden, H | 1 |
| Meijer, CJ | 1 |
| Mulder, H | 2 |
| van Paassen, HC | 1 |
| te Velde, J | 1 |
| de Vries, E | 1 |
| van der Wey, JP | 1 |
| Fromm, GA | 1 |
| Plantalech, L | 1 |
| González, D | 4 |
| Nagant de Deuxchaisnes, C | 1 |
| Rombouts-Lindemans, C | 1 |
| Huaux, JP | 1 |
| Devogelaer, JP | 1 |
| Malghem, J | 2 |
| Maldague, B | 2 |
| Withofs, H | 1 |
| Meersseman, F | 1 |
| Heynen, G | 1 |
| Delwaide, P | 1 |
| Franchimont, P | 1 |
| Adami, S | 1 |
| O'Riordan, JL | 2 |
| Clemens, TL | 1 |
| van Breukelen, FJ | 1 |
| Sleeboom, HP | 1 |
| van Oosterom, AT | 1 |
| Patel, S | 4 |
| Pearson, D | 2 |
| Hosking, DJ | 6 |
| Lioté, F | 2 |
| Boval-Boizard, B | 1 |
| Fritz, P | 2 |
| Kuntz, D | 3 |
| Mazières, B | 3 |
| Macro, M | 1 |
| Bouvard, G | 1 |
| Le Gangneux, E | 1 |
| Colin, T | 1 |
| Loyau, G | 1 |
| Rutland, MD | 1 |
| Gineyts, E | 1 |
| Arbault, P | 1 |
| Delmas, PD | 2 |
| Reid, IR | 3 |
| Mills, DA | 1 |
| Wallace, E | 1 |
| Wong, J | 1 |
| Coupland, CA | 1 |
| Stone, MD | 4 |
| De, S | 1 |
| Meyer, P | 1 |
| Perrot, S | 1 |
| Mortier, E | 1 |
| Renoux, M | 1 |
| Job-Deslandre, C | 1 |
| Menkès, CJ | 2 |
| Siris, ES | 2 |
| Roldán, EJ | 2 |
| Chakravarty, K | 2 |
| Merry, P | 2 |
| Scott, DG | 2 |
| Ing, EB | 1 |
| Savino, PJ | 1 |
| Bosley, TM | 1 |
| Sergott, RC | 1 |
| Kelepouris, N | 1 |
| Adamson, BB | 2 |
| Gallacher, SJ | 5 |
| Byars, J | 2 |
| Ralston, SH | 4 |
| Boyle, IT | 5 |
| Boyce, BF | 3 |
| Anderson, DC | 7 |
| Richardson, PC | 3 |
| King, AR | 2 |
| Bombassei, GJ | 1 |
| Yocono, M | 1 |
| Raisz, LG | 1 |
| Vega, E | 2 |
| Pérez Lloret, A | 1 |
| Ghose, K | 1 |
| Waterworth, R | 1 |
| Trolove, P | 1 |
| Highton, J | 1 |
| Sharp, CA | 2 |
| Worsfold, M | 2 |
| Rowlands, PR | 2 |
| Davie, MW | 3 |
| Wimalawansa, SJ | 2 |
| Brown, JK | 1 |
| Freemont, AJ | 1 |
| Hollis, S | 2 |
| Denton, J | 1 |
| Buckler, HM | 5 |
| Hargreaves, S | 1 |
| Cantrill, JA | 4 |
| Hooper, MJ | 1 |
| Clifton-Bligh, P | 1 |
| Marel, GM | 1 |
| Lang, FV | 1 |
| Tancred, J | 1 |
| McDowall, D | 1 |
| Forman, L | 1 |
| Thiebaud, D | 6 |
| Portmann, L | 2 |
| Burckhardt, P | 6 |
| Haddaway, MJ | 1 |
| Watts, RA | 2 |
| Skingle, S | 1 |
| Bhambani, M | 1 |
| Pountain, G | 2 |
| Grauer, A | 3 |
| Klar, B | 2 |
| Scharla, SH | 3 |
| Zieglar, R | 1 |
| Prince, RI | 1 |
| Macarol, V | 1 |
| Fraunfelder, FT | 1 |
| Thomas, DW | 1 |
| Shepherd, JP | 1 |
| Devlin, RD | 1 |
| Fenton, AJ | 2 |
| Grill, V | 1 |
| Worth, GK | 2 |
| Ryan, PJ | 3 |
| Fogelman, I | 3 |
| Pepersack, T | 1 |
| Karmali, R | 1 |
| Gillet, C | 1 |
| François, D | 1 |
| Fuss, M | 1 |
| Skingle, SJ | 1 |
| Bhambhani, MM | 1 |
| Hamdy, NA | 1 |
| Colwell, A | 1 |
| Russell, RG | 1 |
| Gordon, MT | 1 |
| Bell, SC | 1 |
| Mee, AP | 1 |
| Mercer, S | 1 |
| Carter, SD | 1 |
| Sharpe, PT | 1 |
| Gunasekera, RD | 1 |
| Coupland, C | 1 |
| Cormier, C | 1 |
| Hilliquin, P | 1 |
| Wilczek, H | 2 |
| Stĕpán, J | 1 |
| Hankey, DP | 1 |
| Hughes, AE | 1 |
| Mollan, RA | 1 |
| Nicholas, RM | 1 |
| Schweitzer, DH | 1 |
| Vermeij, P | 3 |
| Johnston, CA | 1 |
| Staehelin-Bosshard, A | 2 |
| Meunier, PJ | 2 |
| Vignot, E | 1 |
| Constable, IJ | 1 |
| Wattie, D | 2 |
| Knaus, J | 1 |
| Ziegler, R | 2 |
| Randall, AG | 1 |
| Garcia-Webb, P | 1 |
| Pearce, DJ | 1 |
| Stewart, G | 1 |
| Stuckey, B | 1 |
| Ward, L | 2 |
| Ahmed, I | 1 |
| Moulinier, L | 1 |
| Bon, E | 1 |
| Cantagrel, A | 1 |
| Laroche, M | 2 |
| Bonde, M | 1 |
| Qvist, P | 1 |
| Ismail, AA | 1 |
| Fox, P | 1 |
| Stamp, TC | 2 |
| Dhillon, V | 1 |
| MacGregor, A | 1 |
| Martínez, ME | 1 |
| Del Campo, MT | 1 |
| Plaza, MA | 1 |
| Torrijos, A | 1 |
| Gijón, J | 1 |
| Kobayashi, H | 1 |
| Shigeno, C | 1 |
| Sakahara, H | 1 |
| Yamamoto, T | 1 |
| Hosono, M | 1 |
| Fujimoto, R | 1 |
| Konishi, J | 1 |
| Coukell, AJ | 1 |
| Markham, A | 1 |
| Pastrana, M | 1 |
| Bagur, A | 1 |
| Arce, G | 1 |
| Rosano, TG | 1 |
| Peaston, RT | 1 |
| Bone, HG | 1 |
| Woitge, HW | 1 |
| Francis, RM | 1 |
| Seibel, MJ | 1 |
| Broyles, DL | 1 |
| Nielsen, RG | 1 |
| Bussett, EM | 1 |
| Lu, WD | 1 |
| Mizrahi, IA | 1 |
| Nunnelly, PA | 1 |
| Ngo, TA | 1 |
| Noell, J | 1 |
| Christenson, RH | 1 |
| Kress, BC | 1 |
| Mercer, SJ | 1 |
| Davison, CE | 1 |
| Anderson, DG | 1 |
| Gburek, Z | 1 |
| Rybicki, A | 1 |
| Selby, PL | 1 |
| Delpech, B | 1 |
| Bernard, J | 1 |
| Constantin, A | 1 |
| Criddle, A | 1 |
| Faulkner, DL | 1 |
| Geelhoed, E | 1 |
| Gan, SK | 1 |
| Trombetti, A | 1 |
| Arlot, M | 1 |
| Thevenon, J | 1 |
| Uebelhart, B | 1 |
| MacGowan, JR | 1 |
| Pringle, J | 1 |
| Morris, VH | 1 |
| Basaria, S | 1 |
| McCarthy, EF | 1 |
| Belzberg, AJ | 1 |
| Ball, DW | 1 |
| Lim, EM | 1 |
| Griffith, K | 1 |
| Parker, C | 1 |
| Thorpe, S | 1 |
| Vincent, RM | 1 |
| Mikosch, P | 1 |
| Pietschmann, P | 1 |
| Kainberger, F | 1 |
| Gallowitsch, HJ | 1 |
| Lind, P | 1 |
| Sherry, M | 1 |
| Gibson, T | 2 |
| Kellihan, MJ | 1 |
| Mangino, PD | 1 |
| Cassinelli, HR | 1 |
| Heinrich, JJ | 1 |
| Miglietta, A | 1 |
| Bergada, C | 1 |
| Brumsen, C | 1 |
| Bloem, RM | 1 |
| Foley-Nolan, D | 1 |
| Daly, MJ | 1 |
| Williams, D | 1 |
| Wasti, A | 1 |
| Martin, M | 1 |
| Fitton, A | 1 |
| McTavish, D | 1 |
| Patel, U | 2 |
| Jenkins, A | 1 |
| García-Vadillo, JA | 1 |
| Díaz-González, F | 1 |
| García de Vicuña, R | 1 |
| Gómez-Pan, A | 1 |
| Yap, AS | 1 |
| Mortimer, RH | 1 |
| Jacobi, JM | 1 |
| Galligan, JP | 1 |
| Perry-Keene, DA | 1 |
| Khafagi, FA | 1 |
| Fraser, WD | 1 |
| Logue, FC | 1 |
| O'Reilly, DS | 1 |
| Beastall, GH | 1 |
| Watson, IG | 1 |
| Barry-Walsh, C | 1 |
| Hawthorne, AB | 1 |
| Kerr, D | 1 |
| Webster, G | 1 |
| McKillop, JH | 1 |
| Miravet, L | 1 |
| Ryan, WG | 1 |
| Mallette, LE | 1 |
| Rapado, A | 1 |
| Palacios, MC | 1 |
| Yagüe, M | 1 |
| Torres, R | 1 |
| de la Piedra, C | 1 |
| Jaeger, P | 4 |
| Jacquet, AF | 2 |
| Daley-Yates, PT | 1 |
| Gifford, LA | 1 |
| Hoggarth, CR | 1 |
| Drake, S | 1 |
| Massie, JD | 1 |
| Postlethwaite, AE | 1 |
| Palmieri, GM | 1 |
| Hoekman, K | 1 |
| Löwik, CW | 1 |
| Harinck, HI | 5 |
| Blanksma, HJ | 2 |
| Dahlinghaus-Nienhuys, PJ | 1 |
| Dodd, GW | 1 |
| Moolenaar, AJ | 1 |
| Anderson, D | 1 |
| Cantrill, JC | 1 |
| Stutzmann, JJ | 1 |
| Petrovic, AG | 1 |
| Fleisch, H | 1 |
| O'Driscoll, JB | 1 |
| Cantrill, J | 1 |
| Brown, JD | 1 |
| Gobelet, C | 1 |
| Ghiringhelli, G | 2 |
| Frolich, M | 1 |
| Mudde, AH | 1 |
| vd Berg, H | 1 |
| Gleed, JH | 1 |
| Fraher, LJ | 1 |
| Vellenga, CJ | 2 |
| Mulder, JD | 1 |
| Pauwels, EK | 1 |
| Dewis, P | 1 |
| Prasad, BK | 1 |
| Willets, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer[NCT00264420] | Phase 1 | 4 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
17 reviews available for pamidronate and Osseous Paget's Disease
| Article | Year |
|---|---|
Paget's Disease of Bone in Patients under 40 Years: Two case reports and review of the literature.
Topics: Adenocarcinoma; Adult; Alkaline Phosphatase; Female; Humans; Magnetic Resonance Imaging; Male; Ostei | 2021 |
Paget disease of bone: therapeutic options.
Topics: Alendronate; Alkaline Phosphatase; Anti-Inflammatory Agents; Diphosphonates; Etidronic Acid; Humans; | 2008 |
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections, Intraveno | 2009 |
Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy.
Topics: Alkaline Phosphatase; Audiometry, Pure-Tone; Biomarkers; Biopsy; Bone Conduction; Bone Density; Bone | 2004 |
[Pharmacological treatment of osteitis deformans (Paget's bone disease)].
Topics: Alendronate; Analgesics, Non-Narcotic; Antimetabolites; Calcitonin; Clodronic Acid; Diphosphonates; | 2005 |
[Paget's disease and its therapeutic management].
Topics: Administration, Oral; Alkaline Phosphatase; Biomarkers; Diphosphonates; Etidronic Acid; Follow-Up St | 2005 |
[Treatment of Paget's disease of bone: importance of the zoledronic acid].
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Resorption; Calcitonin; Dipho | 2006 |
Acquired resistance to bisphosphonates in Paget's disease of bone.
Topics: Diphosphonates; Drug Resistance; Humans; Osteitis Deformans; Pamidronate | 2006 |
A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Disease Progression; Etidronic Acid; Humans; | 2008 |
Paget's disease of bone: current concepts in pathogenesis and treatment.
Topics: Cell Transformation, Neoplastic; Diphosphonates; Humans; Osteitis Deformans; Pamidronate; Radionucli | 1994 |
Perspectives: a practical guide to the use of pamidronate in the treatment of Paget's disease.
Topics: Diphosphonates; Drug Administration Schedule; Humans; Osteitis Deformans; Osteoclasts; Pamidronate; | 1994 |
Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.
Topics: Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Diphosphonates; Humans; Hypercalcemia; Neopl | 1998 |
Pamidronate in the treatment of Paget's disease.
Topics: Anti-Inflammatory Agents; Diphosphonates; Humans; Osteitis Deformans; Pamidronate | 1999 |
Pamidronate.
Topics: Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Humans; Hypercalcemia; Osteitis Deformans; | 1992 |
Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Topics: Animals; Bone Resorption; Diphosphonates; Drug Evaluation; Humans; Hypercalcemia; Osteitis Deformans | 1991 |
Dynamic radiologic patterns of Paget's disease of bone.
Topics: Biomechanical Phenomena; Bone and Bones; Bone Development; Bone Resorption; Calcitonin; Diphosphonat | 1987 |
[Biphosphonate as a therapeutic drug--experimental studies and clinical application].
Topics: Animals; Calcinosis; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hyperpar | 1985 |
27 trials available for pamidronate and Osseous Paget's Disease
| Article | Year |
|---|---|
Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical bone.
Topics: Aged; Analysis of Variance; Bone Density; Bone Resorption; Diphosphonates; Female; Follow-Up Studies | 2003 |
Bisphosphonate resistance in Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Anti-Inflammatory Agents; Clodronic Acid | 2003 |
Effect of bisphosphonate treatment in patients with Paget's disease of the skull.
Topics: Aged; Aged, 80 and over; Audiometry; Diphosphonates; Female; Follow-Up Studies; Hearing Loss, Sensor | 2004 |
A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
Topics: Administration, Oral; Aged; Alendronate; Alkaline Phosphatase; Biomarkers; Bone and Bones; Calcium; | 2004 |
The analgesic effect of pamidronate is not caused by the elevation of beta endorphin level in Paget's disease--a controlled pilot study.
Topics: Aged; Analgesics; beta-Endorphin; Bone Density Conservation Agents; Diphosphonates; Female; Humans; | 2006 |
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone.
Topics: Aged; Diphosphonates; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Hu | 2007 |
Paget's disease of bone.
Topics: Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate | 1982 |
Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Remodeling; Diphosphonates; Follow-Up Studies; Half-Life; | 1995 |
A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Child; Creatinine; Diphosphonates; Female; Humans; Hy | 1994 |
Effects of intravenous pamidronate therapy on Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium; Diphosphonates; Female; Humans; Hydroxyproli | 1994 |
Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile.
Topics: Aged; Alkaline Phosphatase; Body Temperature; Bone and Bones; Calcium; Diphosphonates; Ergocalcifero | 1994 |
Intravenous pamidronate: evolution of an effective treatment strategy.
Topics: Aged; Alkaline Phosphatase; Diphosphonates; Drug Administration Schedule; Humans; Hydroxyproline; In | 1994 |
Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
Topics: Alkaline Phosphatase; Calcitonin; Creatinine; Diphosphonates; Drug Administration Schedule; Drug Res | 1993 |
[Bisphosphonate therapy of Paget's disease of bone with pamidronate].
Topics: Aged; Bone Resorption; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedul | 1996 |
Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
Topics: Aged; Aged, 80 and over; Amino Acids; Analysis of Variance; Biomarkers; Bone Remodeling; Cross-Linki | 1996 |
Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Analysis of Variance; Bone and Bones; Diphosphonates; | 1996 |
Pamidronate infusions for the treatment of Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Chi-Square Distribution; Diphosphonates; Dose-Respons | 1996 |
Pamidronate and biochemical markers of bone turnover.
Topics: Acid Phosphatase; Adult; Aged; Amino Acids; Biomarkers; Bone and Bones; Bone Resorption; Calcitriol; | 1997 |
Urinary free deoxypyridinoline by chemiluminescence immunoassay: analytical and clinical evaluation.
Topics: Adult; Amino Acids; Animals; Antibodies, Monoclonal; Biomarkers; Bone Diseases; Diphosphonates; Fema | 1998 |
Evaluation of adverse experiences related to pamidronate infusion in Paget's disease of bone.
Topics: Aged; Anti-Inflammatory Agents; Diphosphonates; Double-Blind Method; Female; Fever; Headache; Humans | 1998 |
Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium.
Topics: Administration, Oral; Aged; Aged, 80 and over; Bone Density; Calcitriol; Calcium, Dietary; Diphospho | 1999 |
Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another.
Topics: Aged; Alendronate; Diphosphonates; Drug Resistance; Female; Humans; Male; Osteitis Deformans; Pamidr | 1999 |
Effect of multiple intravenous pamidronate courses in Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone Demineralization, Pathologic; Diphosp | 1999 |
Pamidronate.
Topics: Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Humans; Hypercalcemia; Osteitis Deformans; | 1992 |
Clinical experience with pamidronate in the treatment of Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Creatinine; Diphosphonates; Dose-Response Rela | 1991 |
Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
Topics: Administration, Oral; Alkaline Phosphatase; Biopsy; Bone and Bones; Clinical Trials as Topic; Clodro | 1987 |
Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
Topics: Aged; Alkaline Phosphatase; Clinical Trials as Topic; Creatinine; Diphosphonates; Etidronic Acid; Hu | 1985 |
132 other studies available for pamidronate and Osseous Paget's Disease
| Article | Year |
|---|---|
Updates on Paget's Disease of Bone.
Topics: Bone and Bones; Bone Resorption; Diphosphonates; Humans; Osteitis Deformans; Pamidronate | 2022 |
Rhizomelia and Impaired Linear Growth in a Girl with Juvenile Paget Disease: The Natural History of the Condition.
Topics: Adolescent; Child; Child, Preschool; Denosumab; Female; Femur; Growth Plate; Humans; Humerus; Osteit | 2021 |
Acquired resistance to pamidronate treated effectively with zoledronate in juvenile Paget's disease.
Topics: Bone Density Conservation Agents; Drug Resistance; Drug Substitution; Gene Deletion; Humans; Infant; | 2018 |
Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK.
Topics: Adolescent; Amino Acid Sequence; Base Sequence; Child; Child, Preschool; Dentition; Diphosphonates; | 2014 |
Paget's disease of bone and osteonecrosis.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Dry Socket; Female; Humans; Hypercementosis; | 2009 |
[Paget's disease and hypercalcemia: coincidence or causal relationship?].
Topics: Aged; Anti-Inflammatory Agents; Diphosphonates; Female; Fractures, Bone; Humans; Hypercalcemia; Oste | 2009 |
Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation.
Topics: Adult; Amino Acid Substitution; Bone Density Conservation Agents; Child, Preschool; Craniosynostoses | 2013 |
Successful treatment of optic neuropathy in osteitis deformans.
Topics: Aged; Anti-Inflammatory Agents; Dexamethasone; Diphosphonates; Drug Therapy, Combination; Humans; Ma | 2002 |
Investigation of bone disease using isomerized and racemized fragments of type I collagen.
Topics: Adult; Aged; Biomarkers; Bone Diseases; Bone Neoplasms; Bone Resorption; Cells, Cultured; Collagen; | 2003 |
[Fibrous dysplasia: differential diagnosis from Paget's disease].
Topics: Absorptiometry, Photon; Adult; Anti-Inflammatory Agents; Biopsy; Bone Diseases, Metabolic; Diagnosis | 2002 |
Magnetic resonance imaging presentation of lytic Paget's disease of the cervical spine.
Topics: Aged; Alkaline Phosphatase; Cervical Vertebrae; Diphosphonates; Humans; Magnetic Resonance Imaging; | 2002 |
Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate.
Topics: Aged; Analysis of Variance; Cholesterol, HDL; Cholesterol, LDL; Diphosphonates; Female; Humans; Infu | 2003 |
The renal clearance of free and peptide-bound deoxypyridinoline: response to pamidronate treatment of Paget's disease.
Topics: Aged; Aged, 80 and over; Amino Acids; Collagen; Cross-Linking Reagents; Diphosphonates; Female; Huma | 2003 |
Patterns of pain in Paget's disease of bone and their outcomes on treatment with pamidronate.
Topics: Aged; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow | 2003 |
Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
Topics: Administration, Oral; Alkaline Phosphatase; Calcitriol; Clodronic Acid; Diphosphonates; Drug Toleran | 2004 |
Chronic idiopathic hyperphosphatasia: normalization of bone turnover with cyclical intravenous pamidronate therapy.
Topics: Administration, Oral; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Remodeling; Child; Diph | 2004 |
The treatment of Paget's disease.
Topics: Anti-Inflammatory Agents; Diphosphonates; Drug Administration Schedule; Humans; Osteitis Deformans; | 2005 |
Paget's disease of bone.
Topics: Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Diphosphonates; Humans; Male; Osteitis Deforma | 2005 |
Bisphosphonates and avascular necrosis of the jaw: a possible association.
Topics: Aged; Aged, 80 and over; Alendronate; Anti-Inflammatory Agents; Diphosphonates; Female; Follow-Up St | 2005 |
Hearing loss treated with pamidronate.
Topics: Aged; Anti-Inflammatory Agents; Audiometry; Child; Diphosphonates; Hearing Loss, Sensorineural; Huma | 2005 |
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density Conservation Agents; Collagen Type I; Di | 2007 |
Paget's disease of the bone: a report of three cases.
Topics: Aged; Alkaline Phosphatase; Bone Density Conservation Agents; Chest Pain; Diphosphonates; Female; Hu | 2006 |
Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections, | 2008 |
Bisphosphonates and Paget's disease.
Topics: Diphosphonates; Humans; Organophosphonates; Osteitis Deformans; Pamidronate; Propanolamines | 1980 |
Treatment of Paget's bone disease with the bisphosphonate APD.
Topics: Aged; Alkaline Phosphatase; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Mi | 1983 |
Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
Topics: Aged; Alkaline Phosphatase; Calcitonin; Calcium; Diphosphonates; Drug Therapy, Combination; Etidroni | 1984 |
APD in Paget's disease of bone. Role of the mononuclear phagocyte system?
Topics: Animals; Arthritis, Rheumatoid; Calcitonin; Clodronic Acid; Diphosphonates; Drug Therapy, Combinatio | 1980 |
Treatment of Paget's bone disease with a bisphosphonate.
Topics: Adult; Aged; Alkaline Phosphatase; Diphosphonates; Female; Humans; Male; Middle Aged; Osteitis Defor | 1984 |
Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
Topics: Alkaline Phosphatase; Calcium; Diphosphonates; Fever; Humans; Hydroxyproline; Osteitis Deformans; Pa | 1982 |
Regulation of calcium absorption by 1,25,dihydroxy-vitamin D--studies of the effects of a bisphosphonate treatment.
Topics: Aged; Bone Resorption; Calcitriol; Calcium; Diphosphonates; Humans; Hypocalcemia; Middle Aged; Ostei | 1982 |
Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium.
Topics: Adult; Aged; Bone Resorption; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyro | 1982 |
Quantitative bone scintigraphy in the management of monostotic Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Bone Remodeling; Diphosphonates; Female; Humans; Male; Middle Aged; | 1995 |
Lymphocyte subsets in pamidronate-induced lymphopenia.
Topics: Diphosphonates; Humans; Lymphocyte Subsets; Lymphopenia; Osteitis Deformans; Pamidronate | 1995 |
Treatment of Paget's disease of bone with bisphosphonates.
Topics: Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate | 1995 |
Intravenous aminohydroxypropylidene bisphosphonate does not modify 99mTc-hydroxymethylene bisphosphonate bone scintigraphy. A prospective study.
Topics: Aged; Bone Neoplasms; Diphosphonates; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; M | 1995 |
Tracer flows and 'difficult' organs.
Topics: Bone and Bones; Diphosphonates; Etidronic Acid; Humans; Kidney; Kinetics; Models, Biological; Models | 1995 |
Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Bone Development; Chemical Fractionation; Chromatograph | 1995 |
Ototoxicity associated with intravenous bisphosphonate administration.
Topics: Diphosphonates; Hearing Disorders; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Defo | 1995 |
Pamidronate treatment of the neurologic sequelae of pagetic spinal stenosis.
Topics: Aged; Aged, 80 and over; Diphosphonates; Humans; Male; Osteitis Deformans; Pamidronate; Peripheral N | 1995 |
Pamidronate and uveitis.
Topics: Diphosphonates; Female; Humans; Middle Aged; Osteitis Deformans; Pamidronate; Streptococcus pneumoni | 1995 |
Monostotic Paget's disease involving the calcaneus. Diagnostic and therapeutic problems. Two case-reports.
Topics: Calcaneus; Diphosphonates; Female; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate; Tomog | 1995 |
Extensive personal experience: Paget's disease of bone.
Topics: Animals; Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pain; Pamidronate; | 1995 |
Oral pamidronate in refractory Paget's disease.
Topics: Administration, Oral; Diphosphonates; Humans; Osteitis Deformans; Pamidronate | 1994 |
Hemifacial spasm and osteitis deformans.
Topics: Aged; Botulinum Toxins; Diphosphonates; Facial Bones; Facial Muscles; Female; Humans; Magnetic Reson | 1995 |
Mineralisation defects with pamidronate therapy for Paget's disease.
Topics: Calcification, Physiologic; Diphosphonates; Female; Humans; Male; Osteitis Deformans; Osteomalacia; | 1993 |
Pamidronate and Paget's disease.
Topics: Calcification, Physiologic; Diphosphonates; Humans; Osteitis Deformans; Pamidronate | 1994 |
Osteomalacia after pamidronate for Paget's disease.
Topics: Diphosphonates; Humans; Osteitis Deformans; Osteomalacia; Pamidronate | 1994 |
Mineralisation defects after pamidronate for Paget's disease.
Topics: Calcification, Physiologic; Diphosphonates; Humans; Hyperparathyroidism, Secondary; Osteitis Deforma | 1994 |
Uveitis associated with pamidronate.
Topics: Diphosphonates; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate; Uveitis; Uveitis, Anteri | 1994 |
Response of biochemical markers of bone turnover to pamidronate infusion in Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Collagen; Diphosphonates; Female; | 1994 |
Dramatic response to plicamycin in a patient with severe Paget's disease refractory to calcitonin and pamidronate.
Topics: Aged; Aged, 80 and over; Calcitonin; Diphosphonates; Female; Humans; Osteitis Deformans; Pamidronate | 1994 |
Single-day intravenous pamidronate in Paget's disease.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Dose-Response Relationship, Dr | 1994 |
Use of the bisphosphonate space in treatment and retreatment of Paget's disease.
Topics: Alkaline Phosphatase; Diphosphonates; Humans; Osteitis Deformans; Pamidronate; Remission Induction | 1994 |
Moderate Paget's disease treated with pamidronate: comparison of various infusion rates for a 60-mg single dose.
Topics: Diphosphonates; Drug Administration Schedule; Feasibility Studies; Humans; Infusions, Intravenous; O | 1994 |
Response of 99mTc-MDP scanning and whole-body retention to intravenous pamidronate.
Topics: Aged; Diphosphonates; Female; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate; Radionucli | 1994 |
Treatment of Paget's disease of bone with single-dose intravenous pamidronate.
Topics: Delayed-Action Preparations; Diphosphonates; Humans; Infusions, Intravenous; Osteitis Deformans; Pam | 1994 |
Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Drug Administration Schedule; | 1994 |
Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Female; Humans; Hydroxyproline; Infus | 1994 |
Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
Topics: Alkaline Phosphatase; Diphosphonates; Dose-Response Relationship, Drug; Humans; Hydroxyproline; Infu | 1994 |
Effect of pamidronate on indices of bone turnover in Paget's disease followed for 6 years.
Topics: Aged; Bone Remodeling; Diphosphonates; Female; Follow-Up Studies; Humans; Male; Middle Aged; Osteiti | 1994 |
Pamidronate disodium and possible ocular adverse drug reactions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Conjunctivitis; Diphosphonates; Drug Hypersensitivity; H | 1994 |
Long-term elevation of 1,25-dihydroxyvitamin D after short-term intravenous administration of pamidronate (aminohydroxypropylidene bisphosphonate, APD) in Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Resorption; Calcitriol; Calcium; Diphosphonates; Fe | 1994 |
Paget's disease--five years follow up after pamidronate therapy.
Topics: Aged; Diphosphonates; Follow-Up Studies; Humans; Male; Osteitis Deformans; Pamidronate | 1994 |
Paget's disease of bone: five regimens of pamidronate treatment.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Drug Adm | 1994 |
Treatment of Paget's disease of bone with single dose intravenous pamidronate.
Topics: Aged; Alkaline Phosphatase; Diphosphonates; Female; Humans; Infusions, Intravenous; Male; Middle Age | 1993 |
Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?
Topics: Amino Acids; Biomarkers; Bone Resorption; Calcitonin; Chromatography, High Pressure Liquid; Diphosph | 1993 |
Prevalence of canine distemper antibodies in the pagetic population.
Topics: Adult; Antibodies, Viral; Bone and Bones; Diphosphonates; Distemper Virus, Canine; Humans; In Situ H | 1993 |
Determinants of remission of Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Diphosphonates; Female; Humans; Hydro | 1993 |
Effects of intravenous aminopropylidene bisphosphonate in patients with refractory Paget's disease.
Topics: Aged; Alkaline Phosphatase; Diphosphonates; Female; Humans; Injections, Intravenous; Male; Middle Ag | 1993 |
[Paget's disease of bone and treatment with pamidronate].
Topics: Aged; Diphosphonates; Female; Humans; Male; Middle Aged; Osteitis Deformans; Pamidronate | 1993 |
Extracellular protein secretion of cultured normal and Pagetic osteoblasts.
Topics: Aged; Alkaline Phosphatase; Blotting, Western; Cells, Cultured; Collagen; Cyclic AMP; Dinoprostone; | 1993 |
Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bone Resorption; Diphosphonates; Drug Administ | 1993 |
Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density; Data Interpreta | 1993 |
[Concerning:"Moderate Paget's disease treated with pamidronate (ADP): experience in 43 patients with a single 60 mg perfusion of various duration of 1-to-24 hours" by D. Thièbaud at al. (Schweiz. med. Wschr. 1992; 122:1889-1894)].
Topics: Diphosphonates; Humans; Infusions, Parenteral; Osteitis Deformans; Pamidronate | 1993 |
Therapeutic strategy in Paget's disease of bone.
Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Analgesics, Non-Narcotic; Biomarkers; Bone | 1995 |
Disodium pamidronate has beneficial effect in Paget's disease of bone.
Topics: Diphosphonates; Humans; Osteitis Deformans; Pamidronate | 1996 |
Iritis following intravenous pamidronate.
Topics: Aged; Diphosphonates; Female; Humans; Hypercalcemia; Iritis; Male; Middle Aged; Osteitis Deformans; | 1996 |
High-dose pamidronate in the management of resistant Paget's disease.
Topics: Aged; Alkaline Phosphatase; Bone Resorption; Diphosphonates; Dose-Response Relationship, Drug; Femal | 1996 |
Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
Topics: Adult; Alendronate; Amino Acid Sequence; Antibodies; Biomarkers; Bone Resorption; Collagen; Collagen | 1997 |
Treatment of Paget's disease of bone with intravenous pamidronate: comparison of 2 different modes of treatment.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Disease-Free Survival; Female; Humans | 1997 |
Three phase 99Tcm (V)DMSA scintigraphy in Paget's disease: an indicator of pamidronate effect.
Topics: Aged; Aged, 80 and over; Diphosphonates; Humans; Humerus; Male; Osteitis Deformans; Pamidronate; Rad | 1997 |
[Is beta 2-microglobulin a marker of bone remodeling in Paget's disease of bone?].
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; beta 2-Microglobulin; Biomarkers; Bone Remodel | 1997 |
[Treatment of Paget's disease with olpadronate. Its efficacy in partial responders to oral pamidronate].
Topics: Aged; Diphosphonates; Drug Tolerance; Female; Humans; Male; Osteitis Deformans; Pamidronate; Retrosp | 1997 |
Paget's disease in a vertebral body: sixteen years of evolution in a young patient.
Topics: Administration, Oral; Adult; Biomarkers; Bone Density; Calcium; Diphosphonates; Female; Humans; Lumb | 1998 |
Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Bone Diseases; Bon | 1998 |
[An attempt to treat loosening of the total hip endoprosthesis in Paget disease with Aredia].
Topics: Aged; Anti-Inflammatory Agents; Arthroplasty, Replacement, Hip; Diphosphonates; Female; Humans; Oste | 1998 |
Measurement of bone mineral density by dual X-ray absorptiometry in Paget's disease before and after pamidronate treatment.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone and Bones; Bone Dens | 1999 |
Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
Topics: Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthralgia; Diphosphonates; Etidronic Acid; Fo | 2000 |
Case of an ivory vertebra.
Topics: Alendronate; Alkaline Phosphatase; Biopsy; Bone Marrow; Carcinoid Tumor; Diagnosis, Differential; Di | 2000 |
Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
Topics: Alendronate; Calcitriol; Calcium; Cervical Vertebrae; Diphosphonates; Female; Humans; Hypocalcemia; | 2001 |
The use of a whole body index with bone scintigraphy to monitor the response to therapy in Paget's disease.
Topics: Aged; Aged, 80 and over; Algorithms; Alkaline Phosphatase; Anti-Inflammatory Agents, Non-Steroidal; | 2001 |
[Paget disease or fibrous dysplasia of the radius?--A case report].
Topics: Diagnosis, Differential; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Sched | 2001 |
Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD).
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Creatinine; Diphosphonates; Drug Administration Sched | 1992 |
Familial idiopathic hyperphosphatasia (FIH): response to long-term treatment with pamidronate (APD).
Topics: Administration, Oral; Alkaline Phosphatase; Calcium; Calcium Gluconate; Child, Preschool; Diphosphon | 1992 |
Paget's disease with osteolytic lesions: combining medical and surgical treatments.
Topics: Combined Modality Therapy; Diphosphonates; Femur; Humans; Hyperparathyroidism; Male; Middle Aged; Os | 1992 |
[Moderate Paget's disease treated with pamidronate (APD): experience in 43 patients with a single 60 mg infusion of varying duration of 1-to-24 hours].
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Ambulatory Care; Creatinine; Diphosphonates; F | 1992 |
Bone scintigraphy following intravenous pamidronate for Paget's disease of bone.
Topics: Alkaline Phosphatase; Creatinine; Diphosphonates; Humans; Hydroxyproline; Infusions, Intravenous; Os | 1992 |
Pamidronate associated hallucinations.
Topics: Aged; Diphosphonates; Hallucinations; Humans; Male; Osteitis Deformans; Pamidronate | 1992 |
Pamidronate.
Topics: Clinical Trials as Topic; Diphosphonates; Humans; Hypercalcemia; Hyperparathyroidism; Neoplasms; Ost | 1992 |
[Amino-hydroxy-propane diphosphonate (APD): satisfactory therapeutic response in a patient with Paget's disease of bone].
Topics: Diphosphonates; Female; Humans; Middle Aged; Osteitis Deformans; Pamidronate | 1991 |
Single-dose intravenous pamidronate is effective alternative therapy for Paget's disease refractory to calcitonin.
Topics: Aged; Calcitonin; Calcium; Diphosphonates; Drug Resistance; Female; Humans; Hyperparathyroidism, Sec | 1991 |
Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
Topics: Aged; Calcium; Cyclic AMP; Diphosphonates; Female; Glomerular Filtration Rate; Humans; Hypercalcemia | 1991 |
[Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)].
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Bone Density; Diphosphonates; Female; Follow-Up Studies; | 1991 |
Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses.
Topics: Adult; Aged; Bone and Bones; Diphosphonates; Drug Administration Schedule; Female; Humans; Hydroxypr | 1991 |
Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
Topics: Alkaline Phosphatase; Calcium; Diphosphonates; Drug Administration Schedule; Follow-Up Studies; Huma | 1990 |
Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment.
Topics: Aged; Aged, 80 and over; Diphosphonates; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteitis | 1990 |
[Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcitonin; Diphosphonates; Drug Administratio | 1989 |
'Breaking the back' of Paget's bone disease.
Topics: Calcitonin; Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate; Plicamycin | 1989 |
Successful treatment of resistant Paget's disease of bone with pamidronate.
Topics: Adult; Alkaline Phosphatase; Animals; Calcitonin; Diphosphonates; Drug Resistance; Humans; Male; Ost | 1989 |
[Treatment of Paget's disease with AHPrBP].
Topics: Diphosphonates; Drug Evaluation; Humans; Osteitis Deformans; Pamidronate | 1989 |
[A single infusion of Pamidronate (APD) in Paget's disease of bone].
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Resorption; Diphosphonates; Female; Humans; Hydr | 1989 |
Assay of 1-hydroxy-3-aminopropylidene-1,1-bisphosphonate and related bisphosphonates in human urine and plasma by high-performance ion chromatography.
Topics: Chromatography, High Pressure Liquid; Diphosphonates; Humans; Osteitis Deformans; Pamidronate; Phosp | 1989 |
Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
Topics: Alkaline Phosphatase; Calcitonin; Calcium; Calcium-Binding Proteins; Diphosphonates; Humans; Hydroxy | 1989 |
Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonate.
Topics: Administration, Oral; Aged; Animals; Bone and Bones; Bone Resorption; Clinical Protocols; Diphosphon | 1989 |
New drugs for Paget's disease.
Topics: Calcitonin; Diphosphonates; Humans; Osteitis Deformans; Pamidronate | 1986 |
Treating Paget's disease.
Topics: Diphosphonates; Etidronic Acid; Humans; Osteitis Deformans; Pamidronate | 1987 |
Radiological assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APD.
Topics: Aged; Diphosphonates; Etidronic Acid; Female; Femur; Humans; Male; Middle Aged; Osteitis Deformans; | 1987 |
Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Body Temperature; Diphos | 1987 |
Treatment of Paget's disease of bone.
Topics: Aged; Diphosphonates; Humans; Infusions, Intravenous; Osteitis Deformans; Pamidronate | 1988 |
Diphosphonates for otospongiosis.
Topics: Adult; Bone Development; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Ma | 1985 |
Relapse of osteoporosis circumscripta as a lytic ring after treatment of Paget's disease with intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate.
Topics: Adult; Diphosphonates; Female; Humans; Injections, Intravenous; Osteitis Deformans; Osteoporosis; Pa | 1988 |
A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium-Binding Proteins; Diphosphonates; Drug Admini | 1988 |
Paget's disease of bone treated in five days with AHPrBP (APD) per Os.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Female; Humans; Hydroxyproline; Male; | 1987 |
Intravenous aminopropylidene bisphosphonate (APD) in the treatment of Paget's bone disease.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium; Diphosphonates; Female; Humans; Infusions, I | 1987 |
Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium-Binding Proteins; Diphosphonates; Fema | 1987 |
Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD.
Topics: Calcium; Diphosphonates; Humans; Hypercalcemia; Osteitis Deformans; Pamidronate; Parathyroid Hormone | 1986 |
[Paget's disease of bone treated with APD in 5 days].
Topics: Aged; Diphosphonates; Humans; Middle Aged; Osteitis Deformans; Pamidronate | 1987 |
[Paget's disease of bone treated per os with APD in 5 days].
Topics: Administration, Oral; Aged; Aged, 80 and over; Diphosphonates; Drug Evaluation; Female; Humans; Male | 1986 |
Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Female; Humans; Infusions, Intravenou | 1986 |
Radiological demonstration of healing in Paget's disease of bone treated with APD.
Topics: Aged; Diphosphonates; Follow-Up Studies; Humans; Middle Aged; Osteitis Deformans; Pamidronate; Radio | 1985 |
Quantitative bone scintigraphy in Paget's disease treated with APD.
Topics: Diphosphonates; Follow-Up Studies; Humans; Osteitis Deformans; Pamidronate; Radionuclide Imaging; Re | 1985 |
Efficacy of the bisphosphonate APD in the control of Paget's bone disease.
Topics: Adult; Aged; Alkaline Phosphatase; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged | 1985 |